Company
United StatesPublic company, NASDAQ: REGNRegeneron Pharmaceuticals Inc (NASDAQ: REGN), Rensselaer, NY – FDA Inspections
Inspection records and compliance data for Regeneron Pharmaceuticals Inc in Rensselaer, New York. 13 FDA inspections on record, 1 Form 483, last inspected March 22, 2024. Publicly traded as NASDAQ: REGN.
Company Profile
This profile covers Regeneron Pharmaceuticals Inc based in Rensselaer, New York, United States.
FDA Inspection History
- FDA inspections
- 13
- OAI
- 0
- VAI
- 7
- NAI
- 3
- Unclassified
- 3
- Form 483s
- 1
- Warning letters
- 0
First inspected March 31, 2010. Last inspected March 22, 2024.
Most cited issue areas
- Procedures not in writing, fully followed3 inspections
- Cleaning System1 inspection
- Investigations of discrepancies, failures1 inspection
FDA inspections (13)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 22, 2024 | VAI | Human Drugs · Drug Quality Assurance | 1230565 |
| February 16, 2024 | Not classified | Human Drugs | 1239760 |
| October 25, 2021 | VAI | Human Drugs · Drug Quality Assurance | 1155063 |
| October 18, 2019 | VAI | Human Drugs · Drug Quality Assurance | 1106821 |
| June 8, 2018 | Not classified | Human Drugs | 1059234 |
| October 5, 2017 | NAI | Human Drugs · Drug Quality Assurance | 1030807 |
| November 4, 2016 | Not classified | Human Drugs | 994334 |
| August 19, 2016 | VAI | Human Drugs · Drug Quality Assurance | 983604 |
| June 13, 2014 | VAI | Human Drugs · Drug Quality Assurance | 883187 |
| May 24, 2013 | VAI | Human Drugs · Drug Quality Assurance | 848983 |
| June 8, 2012 | NAI | Human Drugs · Drug Quality Assurance | 786188 |
| July 29, 2011 | NAI | Human Drugs · Drug Quality Assurance | 736962 |
| March 31, 2010 | VAI | Human Drugs · Drug Quality Assurance | 655413 |
FDA documents
People (6)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Chugai Pharma Manufacturing Co. Ltd.
Wacker Biotech B.V.
Sun Pharmaceutical Medicare Limited
Boehringer Ingelheim Biopharmaceuticals (China) Ltd.
Abbvie Biotechnology Ltd.
Janssen Biotech, Inc.
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Merz Pharma GmbH & Co., KGaA
Eriochem SA
BSP Pharmaceuticals SpA
Company Information
Name
Regeneron Pharmaceuticals Inc
Stock ticker
REGN
Exchange
NASDAQ
Share price
$951.19
Market cap
$98.4B
Price as of
November 13, 2026
FEI Number
1000514603
Address
81 Columbia Tpke, Rensselaer, New York 12144, United States
Country
United States
ID: cd765cfa-95e6-4023-ade2-0ffa382fe2c7